BDBM698801 (4-(3,3-difluoropiperidin-1-yl)-2-((1- ((dimethylamino)methyl)cyclopropyl) methoxy)-5,7-dihydro-6H-pyrrolo [3,4-d]pyrimidin-6-yl)(3-hydroxy-8- iodonaphthalen-1-yl)methanone::US20240317759, Example 11

SMILES N#Cc1cc(Cl)cc2c1C[C@@H](Nc1ncc(C(=O)N3CCC34CC(F)(F)C4)cn1)C2

InChI Key InChIKey=WZHLMNGPIKXGPQ-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 698801   

TargetAutotaxin(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 698801BDBM698801((S)-6-chloro-2-((5-(6,6- difluoro-1- azaspiro[3.3]...)
Affinity DataIC50: 3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2026
Entry Details
US Patent